"Designing Growth Strategies is in our DNA"
Diarrhea is characterized by loose, abnormal, and frequent bowel movement and is one of the most common health problems. According to the World Gastroenterology Organization, an estimated 2 billion cases of diarrhea are recorded each year worldwide with approximately 1.9 million children below five years of age dying due to diarrhea. There are many known causes of diarrhea, namely due to viral, bacterial, or parasitic infections. Some of the serious diseases that cause diarrhea include, inflammatory bowel disease like Crohn's disease, Celiac disease, cancer, among others.
The primary line of treatment of diarrhea includes rehydration with oral rehydration solution or salts (ORS). Over the counter antidiarrheal medications that comprise of Imodium and Loperamide, which are antimotility drugs are usually prescribed to decrease stool passage. The patient is prescribed medications for the treatment of the infection once the cause of diarrhea is diagnosed.
Several research organizations and governments institutes combined with pharmaceutical companies are conducting clinical trials to understand various therapeutic modes to treat and prevent diarrhea. For instance, Boston Pharmaceuticals is studying the safety, tolerability, and efficacy of BOS-589 in treatment of diarrhea caused by Irritable Bowel Syndrome (IBS-D) and is currently in phase 2 clinical trial.
To get details on market share, speak to analyst
As of 2018, approximately 60% of the pipeline candidates for diarrhea are in the phase-2 and phase-3 clinical stage. More than half of the studies are sponsored by research institutes and government organizations.
The report on ‘Diarrhea – Pipeline Review, 2019’ provides a comprehensive overview of the drugs that are in the R&D pipeline by indication or molecule for diarrhea. The report provides a thorough analysis of the distribution of the pipeline products by clinical trial stage, indication, company, therapy area and details such as clinical trial stage, sponsor, description on every product in the pipeline. Products in the preclinical and clinical stage along with dormant & discontinued pipeline candidates are included in the report. The report also covers additional insights such as epidemiology overview and current market scenario for diarrhea.
The report on ‘Diarrhea – Pipeline Review, 2019’, which is built by following a robust research methodology involving primary interviews and desk research, provides a complete overview of the R&D activity and pipeline products to assist companies in developing growth strategies and identifying emerging players.
“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”- One of the Leading Food Companies in Germany
“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”- Intuitive Surgical
“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”- Major Food Company in Japan
“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”- Ziering Medical
“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”- Major Manufacturer of Precision Machine Parts in India
“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”- Hewlett-Packard
“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”- Global Management Consulting Firm